Efficacy and safety of implantable phakic IOL on correction of high myopia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patient with high myopic error with thin cornea , not suitable for corneal refractive surgery
Exclusion criteria
Exclusion criteria: Exclusion criteria included patients with endothelial cell density (ECD) < 2,000 cells/mm2, anterior chamber depth (ACD) < 3 mm, astigmatism < 1.00 D, and patients with keratoconus or other corneal disorders. Also, patients with glaucoma, uveitis, any degree of cataract, myopic CNV, macular hole, previous retinal detachment surgery, intravitreal injections, and any other ocular disorder that may affect visual outcomes, were excluded from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Although Implantable Phakic IOL cause changes on anterior segment parameters it is safe for usage | — |
Secondary
| Measure | Time frame |
|---|---|
| Implantable phakic IOL is safe and effective in treatment of high myopia | — |
Countries
Africa
Contacts
Minis University Hospital Heba Radi Attallah